Therapeutic Application of Endothelial Colony-Forming Cells for Retinal Diseases

In this webinar, Drs. Susumu Sakimoto and Valentina Marchetti discuss their current research on generating human endothelial colony-forming cells (ECFCs) under xeno-free conditions to treat vascular abnormalities in the eye. Vascular abnormalities are a common component of eye diseases that often lead to vision loss. It is possible to use one cell type to rescue another cell type in the face of severe stress. Dr. Susumu will present his study on how human ECFCs injected into the vitreous cavity rescue vaso-obliteration and neurodegeneration in animal models of retinal disease. These results help us understand the mechanism of ECFC-based therapies for ischemic insults and retinal neurodegenerative diseases. Dr. Valentina Marchetti will present a workflow to derive and expand ECFCs under xeno-free conditions using the EC-Cult™-XF ECFC Culture Kit.
Publish Date: February 21, 2018

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.